ITMCTR2100004676尚未招募4 期
A Randomized Controlled Clinical Trial of Shugan Wendan Decoction in Treating Metabolic Syndrome
The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine (Guangdong Provincial Hospital of Traditional Chi0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •(1) Meet the diagnostic criteria of metabolic syndrome
- •(2) It accords with the mutual accumulation of phlegm and blood stasis, and also clamps the syndrome of stagnation of the liver;
- •(3) Aged between 18-75 years old;
- •(4) Those who voluntarily sign the informed consent.
排除标准
- •(1) Patients with severe cardiovascular and cerebrovascular diseases (such as cardiac insufficiency, acute myocardial infarction, cerebral infarction, cerebral hemorrhage, etc.), liver and kidney insufficiency, mental disorders and other diseases; patients with severe complications such as type I diabetes or diabetic ketosis;
- •(2) Those who are unwilling to cooperate with data collection and blood sampling;
- •(3) Women during pregnancy or lactation;
- •(4) Those who use insulin to control blood sugar
- •(5) Other situations that the researcher thinks are not suitable for participating in this research.
研究者
相似试验
进行中（未招募）
1 期
This is a study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)Subjects with moderately to severely active Crohn's diseaseMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-002869-18-BEAbbVie Deutschland GmbH & Co. KG265
进行中（未招募）
1 期
Clinical Trial to compare if seriously-ill adults with constipation due to narcotics have bowel movements sooner after injection with Methylnatrexone or placeboEUCTR2007-000854-30-BESalix Pharmaceuticals Inc254
进行中（未招募）
不适用
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 17.0Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861EUCTR2013-002343-29-GBRegeneron Pharmaceuticals, Inc.803
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease - E5555-G000-201Coronary Artery DiseaseMedDRA version: 8.1Level: PTClassification code 10011078EUCTR2005-006029-94-BEEisai Limited720
已完成
不适用
A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of JNJ-26070109abdominal pain and heartburn10017943NL-OMON30044Janssen-Cilag82